Screener / SEC EDGAR /CIK 0000009326 /10-K filed Feb 20, 2026, compared with Feb 21, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Materials · Chemicals & Allied Products

Balchem Corp BCPC

Compare with peers Embed
FY2025 at a glance

Sales up 8.8%

XBRL, from each 10-K
RevenueStatements
$1.0B from $953.7M in FY2024
FY2016FY2025
Net incomeStatements
$154.8M from $128.5M in FY2024
FY2016FY2025
EPS (diluted)Statements
$4.75 from $3.93 in FY2024
FY2016FY2025
Operating marginStatements
20.2% from 19.2% in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (43)
EPS (ttm)
5.30
Sales (ttm)
1.1B
Net income (ttm)
170.9M
Sales growth
+8.8%
EPS growth
+20.9%
Sales Q/Q
+8.6%
Free cash flow
-
Gross margin
36.5%
Oper. margin
20.7%
Net margin
15.4%
FCF margin
-
R&D / sales
1.8%
Dividend
0.96
Debt/Eq
-
Curr. ratio
2.47
Cash
66.3M
Op. cash flow (ttm)
223.8M
EBITDA
255.0M
EBITDA margin
24.6%
Quick ratio
1.67
Interest cover
19.74
ROIC
12.3%
Payout ratio
20.2%
Goodwill / assets
48.4%
Oper. margin low 5y
15.4%
Tax rate
22.2%
Stock pay / sales
1.7%
Shares out.
31.8M
Shares Y/Y
-0.3%
Book / share
41.75
Cash / share
2.09
Sales / share
34.90
Asset turnover
0.65
Inventory turns
5.07
Days sales out.
51
Sales 3Y CAGR
+3.2%
Sales 5Y CAGR
+8.1%
EPS 3Y CAGR
+13.5%
EPS 5Y CAGR
+12.8%
Employees
1,352
Sales / employee
820K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 1.0B +7.2% a year Net income 154.8M +12.0% a year
FY2016 revenue 553.2M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-19-002288 FY2016 net income 56.0M · NetIncomeLoss, 0001628280-19-002288 553.2M FY2016 FY2017 revenue 594.8M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-20-001968 FY2017 net income 90.1M · NetIncomeLoss, 0001628280-20-001968 594.8M FY2017 FY2018 revenue 643.7M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-21-002578 FY2018 net income 78.6M · NetIncomeLoss, 0001628280-21-002578 643.7M FY2018 FY2019 revenue 643.7M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-22-003669 FY2019 net income 79.7M · NetIncomeLoss, 0001628280-22-003669 643.7M FY2019 FY2020 revenue 703.6M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-23-005074 FY2020 net income 84.6M · NetIncomeLoss, 0001628280-23-005074 703.6M FY2020 FY2021 revenue 799.0M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-24-005397 FY2021 net income 96.1M · NetIncomeLoss, 0001628280-24-005397 799.0M FY2021 FY2022 revenue 942.4M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-25-007202 FY2022 net income 105.4M · NetIncomeLoss, 0001628280-25-007202 942.4M FY2022 FY2023 revenue 922.4M · RevenueFromContractWithCustomerExcludingAssessedTax, 0000009326-26-000007 FY2023 net income 108.5M · NetIncomeLoss, 0000009326-26-000007 922.4M FY2023 FY2024 revenue 953.7M · RevenueFromContractWithCustomerExcludingAssessedTax, 0000009326-26-000007 FY2024 net income 128.5M · NetIncomeLoss, 0000009326-26-000007 953.7M FY2024 FY2025 revenue 1.0B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000009326-26-000007 FY2025 net income 154.8M · NetIncomeLoss, 0000009326-26-000007 1.0B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2025 (9 years).

From the same starting line, FY2016 to FY2025

Revenue, net income and free cash flow, each set to 100 in FY2016. What happened, from the 10-Ks. Not a forecast.

FY2016 = 100
100 150 200 250 Revenue: $553.2M in FY2016, $1.0B in FY2025 REVENUE $1.0B · 1.9x Net income: $56.0M in FY2016, $154.8M in FY2025 NET INCOME $154.8M · 2.8x FY2016 = 100FY2021FY2025
Revenue 1.9x $553.2M to $1.0B
Net income 2.8x $56.0M to $154.8M

Growth per share, FY2015 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Earnings per share +9.7% a year FY2015 $1.89 to FY2025 $4.75, 10 years
Book value per share +10.2% a year FY2015 $14.66 to FY2025 $38.57, 10 years
100 150 200 250 EPS: $1.89 in FY2015, $4.75 in FY2025 EPS $4.75 · 2.5x Book value / share: $14.66 in FY2015, $38.57 in FY2025 BOOK VALUE / SHARE $38.57 · 2.6x FY2015 = 100FY2020FY2025

Each line is set to 100 in FY2015, so a line at 200 has doubled. What was filed, not a forecast. A line is left out when it is not above zero in every year.

Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 $4.75$38.57-
Dec 31, 2024 $3.93$35.15-
Dec 31, 2023 $3.35$32.48-
Dec 31, 2022 $3.25$28.97$2.76
Dec 31, 2021 $2.94$26.84$3.81
Dec 31, 2020 $2.60$25.48$3.64
Dec 31, 2019 $2.45$22.88$3.04
Dec 31, 2018 $2.42$21.32$3.07
Dec 31, 2017 $2.79$19.14$2.58
Dec 31, 2016 $1.75$16.32$2.65
Dec 31, 2015 $1.89$14.66$1.98

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $365.6M
  • − All liabilities $428.8M
  • = Net current asset value -$63.2M
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $1.3B
  • − Goodwill $816.4M
  • − Other intangible assets $133.0M
  • = Tangible book value $308.0M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

BCPC against Materials peers

Among the 88 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
-2.2%+10.5%
+8.8%26th of 85 · median +3.6%
Net margin
2.1%12.0%
15.4%15th of 85 · median 6.8%
Return on equity
3.9%18.5%
12.9%36th of 84 · median 11.5%
BCPC and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
BCPC Balchem Corp$1.1B +8.8%36.5%15.4%12.9%--
NPO Enpro Inc.$1.3B +9.0%43.2%4.9%3.9%14.2%0.32
TREX Trex Co Inc$1.3B +2.0%37.1%13.9%17.6%15.7%-
CSW CSW Industrials, Inc.$1.3B +23.3%42.1%10.2%11.4%14.2%0.69
TGLS Tecnoglass Holdings Inc.$1.1B +10.5%37.3%9.0%12.2%-6.8%0.36
PRM Perimeter Group Inc.$831.5M +16.4%54.5%6.7%4.2%6.5%0.91
All 88 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by product

From $799.0M of sales to $96.1M of profit FY2021

  • Product Sales Revenue $794.5M
  • Royalty Revenue $4.5M
Revenue to Gross profit: $243.2MRevenue to Cost of revenue: $555.8MGross profit to Operating profit: $127.5MGross profit to Operating expenses: $115.7MOperating profit to Net profit: $96.1MOperating profit to Tax & other: $31.4MOperating expenses to R&D: $13.5MOperating expenses to Sales, admin & other: $102.1M Revenue: $799.0M REVENUE $799.0M +14% Y/Y Gross profit: $243.2M · 30% margin GROSS PROFIT $243.2M 30% margin · +9% Y/Y Cost of revenue: $555.8M · 70% of revenue COST OF REVENUE $555.8M 70% of revenue Operating profit: $127.5M · 16% margin OPERATING PROFIT $127.5M 16% margin · +15% Y/Y Operating expenses: $115.7M · 14% of revenue OPERATING EXPENSES $115.7M 14% of revenue Net profit: $96.1M · 12% margin NET PROFIT $96.1M 12% margin · +14% Y/Y Tax & other: $31.4M · 4% of revenue TAX & OTHER $31.4M 4% of revenue R&D: $13.5M · 2% of revenue R&D $13.5M 2% of revenue Sales, admin & other: $102.1M · 13% of revenue SALES, ADMIN & OTHER $102.1M 13% of revenue

From $942.4M of sales to $105.4M of profit FY2022

  • Product Sales Revenue $939.2M
  • Royalty Revenue $3.2M
Revenue to Gross profit: $280.5MRevenue to Cost of revenue: $661.9MGross profit to Operating profit: $145.2MGross profit to Operating expenses: $135.3MOperating profit to Net profit: $105.4MOperating profit to Tax & other: $39.8MOperating expenses to R&D: $12.2MOperating expenses to Sales, admin & other: $123.1M Revenue: $942.4M REVENUE $942.4M +18% Y/Y Gross profit: $280.5M · 30% margin GROSS PROFIT $280.5M 30% margin · +15% Y/Y Cost of revenue: $661.9M · 70% of revenue COST OF REVENUE $661.9M 70% of revenue Operating profit: $145.2M · 15% margin OPERATING PROFIT $145.2M 15% margin · +14% Y/Y Operating expenses: $135.3M · 14% of revenue OPERATING EXPENSES $135.3M 14% of revenue Net profit: $105.4M · 11% margin NET PROFIT $105.4M 11% margin · +10% Y/Y Tax & other: $39.8M · 4% of revenue TAX & OTHER $39.8M 4% of revenue R&D: $12.2M · 1% of revenue R&D $12.2M 1% of revenue Sales, admin & other: $123.1M · 13% of revenue SALES, ADMIN & OTHER $123.1M 13% of revenue

From $922.4M of sales to $108.5M of profit FY2023

  • Product Sales Revenue $920.0M
  • Royalty Revenue $2.5M
Revenue to Gross profit: $302.1MRevenue to Cost of revenue: $620.4MGross profit to Operating profit: $159.2MGross profit to Operating expenses: $142.9MOperating profit to Net profit: $108.5MOperating profit to Tax & other: $50.6MOperating expenses to R&D: $15.0MOperating expenses to Sales, admin & other: $127.8M Revenue: $922.4M REVENUE $922.4M −2% Y/Y Gross profit: $302.1M · 33% margin GROSS PROFIT $302.1M 33% margin · +8% Y/Y Cost of revenue: $620.4M · 67% of revenue COST OF REVENUE $620.4M 67% of revenue Operating profit: $159.2M · 17% margin OPERATING PROFIT $159.2M 17% margin · +10% Y/Y Operating expenses: $142.9M · 15% of revenue OPERATING EXPENSES $142.9M 15% of revenue Net profit: $108.5M · 12% margin NET PROFIT $108.5M 12% margin · +3% Y/Y Tax & other: $50.6M · 5% of revenue TAX & OTHER $50.6M 5% of revenue R&D: $15.0M · 2% of revenue R&D $15.0M 2% of revenue Sales, admin & other: $127.8M · 14% of revenue SALES, ADMIN & OTHER $127.8M 14% of revenue

From $953.7M of sales to $128.5M of profit FY2024

  • Product Sales Revenue $951.9M
  • Royalty Revenue $1.7M
Revenue to Gross profit: $336.2MRevenue to Cost of revenue: $617.5MGross profit to Operating profit: $182.9MGross profit to Operating expenses: $153.3MOperating profit to Net profit: $128.5MOperating profit to Tax & other: $54.4MOperating expenses to R&D: $16.8MOperating expenses to Sales, admin & other: $136.5M Revenue: $953.7M REVENUE $953.7M +3% Y/Y Gross profit: $336.2M · 35% margin GROSS PROFIT $336.2M 35% margin · +11% Y/Y Cost of revenue: $617.5M · 65% of revenue COST OF REVENUE $617.5M 65% of revenue Operating profit: $182.9M · 19% margin OPERATING PROFIT $182.9M 19% margin · +15% Y/Y Operating expenses: $153.3M · 16% of revenue OPERATING EXPENSES $153.3M 16% of revenue Net profit: $128.5M · 13% margin NET PROFIT $128.5M 13% margin · +18% Y/Y Tax & other: $54.4M · 6% of revenue TAX & OTHER $54.4M 6% of revenue R&D: $16.8M · 2% of revenue R&D $16.8M 2% of revenue Sales, admin & other: $136.5M · 14% of revenue SALES, ADMIN & OTHER $136.5M 14% of revenue

From $1.0B of sales to $154.8M of profit FY2025

  • Product Sales Revenue $1.0B
  • Royalty Revenue $1.9M
Revenue to Gross profit: $370.6MRevenue to Cost of revenue: $666.5MGross profit to Operating profit: $209.3MGross profit to Operating expenses: $161.3MOperating profit to Net profit: $154.8MOperating profit to Tax & other: $54.5MOperating expenses to R&D: $18.5MOperating expenses to Sales, admin & other: $142.8M Revenue: $1.0B REVENUE $1.0B +9% Y/Y Gross profit: $370.6M · 36% margin GROSS PROFIT $370.6M 36% margin · +10% Y/Y Cost of revenue: $666.5M · 64% of revenue COST OF REVENUE $666.5M 64% of revenue Operating profit: $209.3M · 20% margin OPERATING PROFIT $209.3M 20% margin · +14% Y/Y Operating expenses: $161.3M · 16% of revenue OPERATING EXPENSES $161.3M 16% of revenue Net profit: $154.8M · 15% margin NET PROFIT $154.8M 15% margin · +21% Y/Y Tax & other: $54.5M · 5% of revenue TAX & OTHER $54.5M 5% of revenue R&D: $18.5M · 2% of revenue R&D $18.5M 2% of revenue Sales, admin & other: $142.8M · 14% of revenue SALES, ADMIN & OTHER $142.8M 14% of revenue

Where each $100 of sales went

FY2021
FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • R&D
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity 12.3% FY2020: 10.2% net income ÷ equity
Net margin 14.9% FY2020: 12.0% profit per $ of sales: 154.8M ÷ 1.0B
Asset turnover 0.62× FY2020: 0.60× sales per $ of assets: 1.0B ÷ 1.7B
Leverage 1.34× FY2020: 1.41× assets per $ of equity: 1.7B ÷ 1.3B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin above the peer median
    15.4% vs 6.8%
  • Gross margin up over 5 years
    31.8% → 35.7%
  • Return on equity below 15%
    12.9%
  • A profit in every one of 10 years
Net margin, FY2016 to FY2025: 10.1% to 14.9%

Balance sheet

  • Interest covered more than 5 times
    Operating income is 19.7× interest expense
  • Current assets cover current liabilities
    Current ratio 2.47
Debt / equity at each year end, FY2016 to FY2025: 0.50 to 0.23

Cash and shareholders

  • Free cash flow positive in every one of 7 years
    $89.5M last year
  • Share count up over 5 years
    +0.3%
  • Dividend per share up over 3 years
    $0.71 → $0.96
  • Cash from operations above net income
    $216.6M vs $154.8M
Free cash flow, FY2016 to FY2025: 84.6M to 89.5M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

BCPC's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue1.0B
FY2016: 553.2MFY2017: 594.8MFY2018: 643.7MFY2019: 643.7MFY2020: 703.6MFY2021: 799.0MFY2022: 942.4MFY2023: 922.4MFY2024: 953.7MFY2025: 1.0B FY2017FY2019FY2021FY2023FY2025
Net income154.8M
FY2016: 56.0MFY2017: 90.1MFY2018: 78.6MFY2019: 79.7MFY2020: 84.6MFY2021: 96.1MFY2022: 105.4MFY2023: 108.5MFY2024: 128.5MFY2025: 154.8M FY2017FY2019FY2021FY2023FY2025
Free cash flow89.5M
FY2016: 84.6MFY2017: 83.1MFY2018: 99.5MFY2019: 98.7MFY2020: 118.4MFY2021: 124.4MFY2022: 89.5MFY2023: -FY2024: -FY2025: - FY2017FY2019FY2021FY2023FY2025
Free cash flow after stock pay76.2M
FY2016: 77.6MFY2017: 76.8MFY2018: 93.1MFY2019: 91.1MFY2020: 110.1MFY2021: 113.6MFY2022: 76.2MFY2023: -FY2024: -FY2025: - FY2017FY2019FY2021FY2023FY2025
EPS (diluted)4.75
FY2016: 1.75FY2017: 2.79FY2018: 2.42FY2019: 2.45FY2020: 2.60FY2021: 2.94FY2022: 3.25FY2023: 3.35FY2024: 3.93FY2025: 4.75 FY2017FY2019FY2021FY2023FY2025
Dividend per share0.96
FY2016: -FY2017: -FY2018: -FY2019: -FY2020: -FY2021: -FY2022: 0.71FY2023: 0.79FY2024: 0.87FY2025: 0.96 FY2017FY2019FY2021FY2023FY2025
Diluted shares32.6M
FY2016: 31.9MFY2017: 32.2MFY2018: 32.4MFY2019: 32.5MFY2020: 32.5MFY2021: 32.7MFY2022: 32.4MFY2023: 32.4MFY2024: 32.7MFY2025: 32.6M FY2017FY2019FY2021FY2023FY2025

Revenue by business segment

year to Dec 31, 2025
RevenueSharevs year before
Human Nutrition and Health 659.4M63.6% +9.9%
Animal Nutrition and Health 230.9M22.3% +7.5%
Specialty Products 141.0M13.6% +6.2%

10-K 0000009326-26-000007, segment and revenue notes (XBRL).

Revenue by product or service

year to Dec 31, 2025
RevenueSharevs year before
Product Sales Revenue 1.0B99.8% +8.8%
Royalty Revenue 1.9M0.2% +8.8%

10-K 0000009326-26-000007, segment and revenue notes (XBRL).

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
United States 759.4M73.2% +5.0%
Foreign Countries 277.7M26.8% +20.5%

10-K 0000009326-26-000007, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Human Nutrition and Health442.7M527.1M550.8M600.3M659.4M
Animal Nutrition and Health226.8M262.3M238.3M214.7M230.9M
Specialty Products117.0M131.4M126.0M132.7M141.0M

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Human Nutrition and Health-82.1M102.4M136.0M153.9M
Specialty Products-32.8M34.6M39.9M42.9M
Animal Nutrition and Health-36.1M27.6M14.0M18.7M
Corporate and other--5.8M-5.4M-7.0M-6.2M

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue553.2M594.8M643.7M643.7M703.6M799.0M942.4M922.4M953.7M1.0B
Cost of revenue372.3M405.8M439.4M432.3M479.7M555.8M661.9M620.4M617.5M666.5M
Gross profit180.9M189.0M204.3M211.4M223.9M243.2M280.5M302.1M336.2M370.6M
R&D7.3M9.3M11.6M11.4M10.3M13.5M12.2M15.0M16.8M18.5M
SG&A27.5M28.1M28.3M36.5M43.8M41.7M55.7M53.4M67.6M67.4M
Operating income90.8M96.9M107.1M102.6M111.1M127.5M145.2M159.2M182.9M209.3M
Interest expense7.3M7.5M6.9M5.7M4.7M4.5M11.9M25.9M17.7M10.6M
Pretax income82.9M88.5M99.0M96.5M106.4M125.2M133.7M137.3M166.5M199.0M
Income tax27.0M-1.6M20.5M16.8M21.8M29.1M28.4M28.7M38.0M44.2M
Net income56.0M90.1M78.6M79.7M84.6M96.1M105.4M108.5M128.5M154.8M
EPS (diluted)1.752.792.422.452.602.943.253.353.934.75
Diluted shares31.9M32.2M32.4M32.5M32.5M32.7M32.4M32.4M32.7M32.6M
Depreciation & amortization46.2M44.4M44.7M45.9M51.3M48.9M51.8M54.9M48.0M45.7M
EBITDA137.0M141.3M151.8M148.4M162.4M176.4M197.0M214.1M230.9M255.0M
Gross margin32.7%31.8%31.7%32.8%31.8%30.4%29.8%32.7%35.3%35.7%
Operating margin16.4%16.3%16.6%15.9%15.8%16.0%15.4%17.3%19.2%20.2%
Net margin10.1%15.1%12.2%12.4%12.0%12.0%11.2%11.8%13.5%14.9%
Revenue growth+0.1%+7.5%+8.2%0.0%+9.3%+13.6%+17.9%-2.1%+3.4%+8.8%
EPS growth-7.4%+59.4%-13.3%+1.2%+6.1%+13.1%+10.5%+3.1%+17.3%+20.9%

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow107.6M110.6M118.7M124.5M150.5M160.5M138.5M183.8M182.0M216.6M
Capital spending23.0M27.5M19.2M25.8M32.1M36.1M49.1M---
Free cash flow84.6M83.1M99.5M98.7M118.4M124.4M89.5M---
Stock-based pay (added back)7.0M6.3M6.4M7.6M8.3M10.8M13.2M16.1M16.7M18.1M
Free cash flow after stock pay77.6M76.8M93.1M91.1M110.1M113.6M76.2M---
Dividends paid10.7M12.1M13.4M15.1M16.7M18.7M20.7M22.9M25.6M28.3M
Buybacks1.6M1.9M1.4M21.3M13.5M35.2M35.4M4.5M5.7M107.6M
Acquisitions110.6M17.4M17.4M141.1M00365.8M1.3M24.2M323K
Debt raised0---------
Debt repaid35.0M43.0M219.5M-------
Investing cash flow-133.6M-42.7M-32.0M-156.2M-34.6M-35.3M-416.0M-34.8M-59.7M-43.9M
Financing cash flow-19.5M-68.6M-71.4M43.4M-101.2M-102.2M246.7M-153.3M-133.8M-152.8M
Dividend per share------0.710.790.870.96

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)7.0M6.3M6.4M7.6M8.3M10.8M13.2M16.1M16.7M18.1M
Stock-based pay / revenue1.3%1.1%1.0%1.2%1.2%1.4%1.4%1.7%1.7%1.7%
Operating lease cost--3.9M3.2M3.1M3.1M4.5M5.3M5.5M5.4M
Operating lease cash paid---3.2M2.9M3.1M4.3M4.8M5.5M5.5M
Finance lease principal paid--00151K159K177K222K216K194K
Right-of-use assets--07.3M5.8M6.9M17.1M17.8M15.3M14.7M
Operating lease liabilities--07.3M5.8M7.0M17.6M18.6M16.1M14.9M
Finance lease liabilities----2.6M2.5M2.4M---

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BCPC/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.